Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 12 studies | 23% ± 7% | |
| pericyte | 8 studies | 22% ± 6% | |
| smooth muscle cell | 8 studies | 19% ± 4% | |
| connective tissue cell | 6 studies | 26% ± 10% | |
| endothelial cell | 5 studies | 20% ± 5% | |
| myofibroblast cell | 3 studies | 24% ± 4% |
Insufficient scRNA-seq data for expression of ARMCX1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 100% | 2754.75 | 258 / 258 | 99% | 91.14 | 228 / 230 |
| brain | 99% | 1741.61 | 2628 / 2642 | 100% | 69.78 | 702 / 705 |
| thymus | 100% | 1819.17 | 652 / 653 | 96% | 38.68 | 583 / 605 |
| breast | 100% | 2360.43 | 459 / 459 | 95% | 55.15 | 1062 / 1118 |
| kidney | 100% | 1198.31 | 89 / 89 | 93% | 30.02 | 839 / 901 |
| skin | 99% | 1564.87 | 1790 / 1809 | 93% | 52.48 | 441 / 472 |
| prostate | 100% | 2017.78 | 244 / 245 | 85% | 30.90 | 427 / 502 |
| pancreas | 94% | 711.03 | 308 / 328 | 90% | 24.23 | 160 / 178 |
| ovary | 100% | 3540.70 | 180 / 180 | 83% | 17.11 | 358 / 430 |
| lung | 100% | 1732.07 | 577 / 578 | 75% | 16.45 | 867 / 1155 |
| uterus | 100% | 3088.49 | 170 / 170 | 49% | 20.24 | 223 / 459 |
| bladder | 100% | 2348.76 | 21 / 21 | 43% | 10.59 | 219 / 504 |
| stomach | 97% | 1260.71 | 350 / 359 | 32% | 5.90 | 92 / 286 |
| esophagus | 94% | 1689.65 | 1363 / 1445 | 34% | 6.12 | 63 / 183 |
| intestine | 96% | 2244.76 | 931 / 966 | 26% | 4.50 | 137 / 527 |
| adipose | 100% | 2486.37 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2845.02 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 69.09 | 80 / 80 |
| spleen | 100% | 1305.16 | 241 / 241 | 0% | 0 | 0 / 0 |
| muscle | 98% | 1429.78 | 790 / 803 | 0% | 0 | 0 / 0 |
| heart | 98% | 1875.81 | 842 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 38% | 4.19 | 11 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 38% | 5.50 | 17 / 45 |
| liver | 7% | 35.56 | 16 / 226 | 19% | 4.38 | 79 / 406 |
| peripheral blood | 2% | 8.65 | 16 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0061484 | Biological process | hematopoietic stem cell homeostasis |
| GO_0005741 | Cellular component | mitochondrial outer membrane |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005515 | Molecular function | protein binding |
| Gene name | ARMCX1 |
| Protein name | Armadillo repeat-containing X-linked protein 1 (ARM protein lost in epithelial cancers on chromosome X 1) (Protein ALEX1) |
| Synonyms | ALEX1 AD032 |
| Description | FUNCTION: Regulates mitochondrial transport during axon regeneration. Increases the proportion of motile mitochondria by recruiting stationary mitochondria into the motile pool. Enhances mitochondria movement and neurite growth in both adult axons and embryonic neurons. Promotes neuronal survival and axon regeneration after nerve injury. May link mitochondria to the Trak1-kinesin motor complex via its interaction with MIRO1. . |
| Accessions | ENST00000372829.8 Q9P291 |
